Letter from the President

Dear ESPT members,

In this second part of 2015 we have to prepare the General Assemblies, an extraordinary for modifying the statutes and an ordinary one for presenting all our activities during the last year:

  • Developing the national societies and the scientific groups

  • Implementing committees

  • Realizing new communication and public relations material = a 6 pages flyer with inserted information on ESPT structures

  • Proposing a nomination committee for the renewal of the Board on 2016 (chaired by Urs Meyer and Magnus Ingelman Sundberg)

We will be participating in the third ESPT congress in Budapest devoted to ‘’Integration of Pharmacogenomics in clinical decision support ‘’with more than 60 oral presentations, 3 workshops, 65 posters, a dedicated exhibition.

The actual participants which are more than 200 are coming from 35 different countries!

We hope to see you also in Budapest and that you will be voting at the General Assemblies.

You support to the development of ESPT scientific and translational Society is essential.

Best regards,

Gérard Siest

President

 

The Society

 

ESPT 

European Society of Pharmacogenomics and Personalised Therapy
 
A Scientific Society for Individualised Medicine
 
 

3rd ESPT Conference:
Integration of Pharmacogenomics in clinical decision support

Corporate Members

DMPT Journalcover dmpt 2015a

The official journal of ESPT is Drug Metabolism and Personalized Therapy(DMPT).
Drug Metabolism and Personalized Therapy provides up-to-date Research Articles, Reviews and Opinion Papers in the wide field of drug metabolism research, covering established, new and potential drugs, environmentally toxic chemicals, the mechanisms by which drugs may interact with each other and with biological systems, and the pharmacological and toxicological consequences of these interactions and drug metabolism and excretion.

Recent News

Members of the ESPT executive board present at the EACPT Congress in Madrid

At the 12th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT) in Madrid 27-30. June 2015, a key session took place on the topic “Implementation of Pharmacogenetics and Personalised Medicine in Clinical Practice from a Health Care perspective: What is a clinical need and what is just business? The session was chaired by Guilherme Suarez-Kurtz (Brazil), Chair of the IUPHAR Section of Pharmacogenetics and Pharmacogenomics and Ingolf Cascorbi (Germany), Executive Board member of ESPT.